SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000950170-23-041524
Filing Date
2023-08-10
Accepted
2023-08-10 18:40:56
Documents
2
Period of Report
2023-08-08

Document Format Files

Seq Description Document Type Size
1 3 ownership.html 3  
1 3 ownership.xml 3 3321
2 EX-24.1 xene-ex24_1.htm EX-24.1 8551
  Complete submission text file 0000950170-23-041524.txt   13230
Mailing Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W
Business Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W (604) 484-3300
Xenon Pharmaceuticals Inc. (Issuer) CIK: 0001582313 (see all company filings)

IRS No.: 980661854 | State of Incorp.: A1 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CORCEPT THERAPEUTICS INCORPORATED 149 COMMONWEALTH DRIVE MENLO PARK CA 94025
Business Address
Cannon Gillian (Reporting) CIK: 0001833910 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36687 | Film No.: 231161045